Development and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring
Protocol for Developing and Validating a Multimodal Brain Monitoring-Based Prognostic Model for Neurocritical Patients: A Prospective, Observational, Multicenter Cohort Study
1 other identifier
observational
200
1 country
1
Brief Summary
This study aims to develop and validate a prognostic model for neurocritical patients using multimodal brain monitoring data. By combining data from various monitoring techniques such as EEG, TCD, and NIRS, this model will help predict 90-day outcomes (awake, comatose, or deceased) and support personalized treatment decisions. The study is observational and involves no experimental interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 8, 2024
CompletedFirst Submitted
Initial submission to the registry
August 3, 2025
CompletedFirst Posted
Study publicly available on registry
August 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
September 17, 2026
September 1, 2026
3 years
August 3, 2025
September 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
90-day Outcome Prediction
The primary outcome is the prediction of patient status at 90 days post-ICU admission, categorized as awake, comatose, or deceased.
90-day
Eligibility Criteria
Neurocritical patients aged 18-80 years with acute brain injury admitted to the ICU.
You may qualify if:
- Aged 18-80 years, no gender restrictions.
- Diagnosed with acute brain injury (ABI), including one of the following: large cerebral infarction, supratentorial large-volume intracerebral hemorrhage, subarachnoid hemorrhage, or severe traumatic brain injury, with imaging evidence (CT or MRI) supporting the diagnosis.
- On ICU admission, Glasgow Coma Scale (GCS) eye response = 1 (no eye opening) and motor score ≤ 5 (does not follow commands); or within 48 hours, neurological deterioration with no eye opening and motor score reduced to ≤ 5 (total GCS score ≤ 8).
- Able to undergo continuous multimodal monitoring, with an expected ICU stay of ≥72 hours.
- Informed consent signed by the family or legal representative.
You may not qualify if:
- Confirmed brain death on admission or imaging showing irreversible brain herniation.
- Severe trauma unrelated to brain injury (e.g., multiple fractures, spinal cord injuries, or visceral rupture) that may interfere with brain function monitoring or outcome assessment.
- Pre-existing severe neurological disorders such as epilepsy, severe encephalopathy, or chronic intracranial conditions (e.g., brain tumors or hydrocephalus).
- Inability to perform multimodal monitoring due to technical issues (e.g., equipment failure or sensor installation problems).
- Predicted survival time \<24 hours after admission, or family members choose to withdraw treatment.
- Refusal to participate in the study by the patient or their legal representative.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
XiangyaHospital of Central South University
Changsha, Hunan, 410080, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2025
First Posted
August 11, 2025
Study Start
January 8, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
September 17, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share individual participant data (IPD) due to privacy, ethical, or regulatory considerations